These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 9622062

  • 1. Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.
    Bahuau M, Vidaud D, Jenkins RB, Bièche I, Kimmel DW, Assouline B, Smith JS, Alderete B, Cayuela JM, Harpey JP, Caille B, Vidaud M.
    Cancer Res; 1998 Jun 01; 58(11):2298-303. PubMed ID: 9622062
    [Abstract] [Full Text] [Related]

  • 2. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A, Gaddipati JP, Moul JW, Srivastava S.
    J Urol; 1998 May 01; 159(5):1725-30. PubMed ID: 9554401
    [Abstract] [Full Text] [Related]

  • 3. Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival.
    Grafström E, Egyházi S, Ringborg U, Hansson J, Platz A.
    Clin Cancer Res; 2005 Apr 15; 11(8):2991-7. PubMed ID: 15837753
    [Abstract] [Full Text] [Related]

  • 4. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers.
    Packenham JP, Taylor JA, White CM, Anna CH, Barrett JC, Devereux TR.
    Clin Cancer Res; 1995 Jul 15; 1(7):687-90. PubMed ID: 9816033
    [Abstract] [Full Text] [Related]

  • 5. Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
    Flores JF, Walker GJ, Glendening JM, Haluska FG, Castresana JS, Rubio MP, Pastorfide GC, Boyer LA, Kao WH, Bulyk ML, Barnhill RL, Hayward NK, Housman DE, Fountain JW.
    Cancer Res; 1996 Nov 01; 56(21):5023-32. PubMed ID: 8895759
    [Abstract] [Full Text] [Related]

  • 6. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors.
    Lubomierski N, Kersting M, Bert T, Muench K, Wulbrand U, Schuermann M, Bartsch D, Simon B.
    Cancer Res; 2001 Aug 01; 61(15):5905-10. PubMed ID: 11479232
    [Abstract] [Full Text] [Related]

  • 7. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK, Zanation AM, Moss JR, Yarbrough WG.
    Laryngoscope; 2002 Sep 01; 112(9):1587-93. PubMed ID: 12352668
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma.
    Gao L, Liu L, van Meyel D, Cairncross G, Forsyth P, Kimmel D, Jenkins RB, Lassam NJ, Hogg D.
    Clin Cancer Res; 1997 Jun 01; 3(6):977-81. PubMed ID: 9815774
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of the INK4 family of genes in prostate carcinomas.
    Park DJ, Wilczynski SP, Pham EY, Miller CW, Koeffler HP.
    J Urol; 1997 May 01; 157(5):1995-9. PubMed ID: 9112579
    [Abstract] [Full Text] [Related]

  • 11. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
    Merbs SL, Sidransky D.
    Invest Ophthalmol Vis Sci; 1999 Mar 01; 40(3):779-83. PubMed ID: 10067984
    [Abstract] [Full Text] [Related]

  • 12. Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma.
    Xiao S, Li D, Corson JM, Vijg J, Fletcher JA.
    Cancer Res; 1995 Jul 15; 55(14):2968-71. PubMed ID: 7606711
    [Abstract] [Full Text] [Related]

  • 13. A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
    Knappskog S, Geisler J, Arnesen T, Lillehaug JR, Lønning PE.
    Genes Chromosomes Cancer; 2006 Dec 15; 45(12):1155-63. PubMed ID: 17001621
    [Abstract] [Full Text] [Related]

  • 14. Codeletion of p15 and p16 in primary malignant mesothelioma.
    Xio S, Li D, Vijg J, Sugarbaker DJ, Corson JM, Fletcher JA.
    Oncogene; 1995 Aug 03; 11(3):511-5. PubMed ID: 7630635
    [Abstract] [Full Text] [Related]

  • 15. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J, Li Y, Li H, Wu Q, Hou J, Liew C.
    Chin Med J (Engl); 2000 Sep 03; 113(9):817-22. PubMed ID: 11776078
    [Abstract] [Full Text] [Related]

  • 16. Germline p16INK4A mutation and protein dysfunction in a family with inherited melanoma.
    Liu L, Lassam NJ, Slingerland JM, Bailey D, Cole D, Jenkins R, Hogg D.
    Oncogene; 1995 Jul 20; 11(2):405-12. PubMed ID: 7624155
    [Abstract] [Full Text] [Related]

  • 17. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus.
    Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J.
    Nat Genet; 1994 Sep 20; 8(1):23-6. PubMed ID: 7987388
    [Abstract] [Full Text] [Related]

  • 18. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
    Parris CN, Harris JD, Griffin DK, Cuthbert AP, Silver AJ, Newbold RF.
    Cancer Res; 1999 Feb 01; 59(3):516-20. PubMed ID: 9973191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S, Ahmed MI, Said H, Zaghlool A, El-Ahmady O.
    IUBMB Life; 2004 Sep 01; 56(9):557-64. PubMed ID: 15590562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.